Valuation: Synovics Pharmaceuticals, Inc.

Market Cap 1.64M 1.46M 1.34M 1.22M 2.29M 155M 2.34M 16.05M 6.47M 81.97M 6.16M 6.03M 259M P/E 2007
-0.73x
P/E 2008 -2.06x
Enterprise Value 8.13M 7.26M 6.66M 6.06M 11.36M 770M 11.58M 79.55M 32.06M 406M 30.51M 29.86M 1.28B EV / Sales 2007
1.81x
EV / Sales 2008 0.6x
Free-Float
95.75%
Yield 2007 *
-
Yield 2008 -
1 day+9,900.00%
6 months+9,900.00%
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0
10 years 0
Extreme 1.0E-6
0
Change 5-day change 1-year change 3-year change Capi.($)
+9,900.00%-.--%-.--%-.--% 3.65K
-0.36%+10.25%+57.30%+143.03% 1,263B
-1.41%+1.05%+44.48%+79.11% 658B
-2.20%+0.65%+36.15%+101.45% 521B
-1.54%+0.18%+53.06%+66.79% 391B
-0.46%+5.53%+79.88%+44.27% 369B
-1.69%+3.17%+32.18%+55.35% 307B
-0.72%+7.83%+12.10%+33.76% 290B
+0.15%+4.81%+57.28%+74.81% 252B
-0.04%+7.00%+39.12%+109.03% 212B
Average +989.15%+5.31%+41.16%+70.76% 426.19B
Weighted average by Cap. -0.95%+6.60%+48.51%+93.07%

Financials

2007 2008
Net sales 23.47M 20.95M 19.23M 17.49M 32.79M 2.22B 33.44M 230M 92.56M 1.17B 88.07M 86.19M 3.7B 25.96M 23.18M 21.27M 19.35M 36.27M 2.46B 36.99M 254M 102M 1.3B 97.43M 95.35M 4.1B
Net income -20.86M -18.62M -17.09M -15.54M -29.14M -1.97B -29.72M -204M -82.27M -1.04B -78.28M -76.61M -3.29B -4.01M -3.58M -3.28M -2.99M -5.6M -379M -5.71M -39.2M -15.8M -200M -15.03M -14.71M -632M
Net Debt 18.79M 16.78M 15.39M 14M 26.25M 1.78B 26.78M 184M 74.12M 939M 70.52M 69.02M 2.97B 6.49M 5.79M 5.32M 4.84M 9.07M 614M 9.25M 63.49M 25.59M 324M 24.35M 23.83M 1.02B
Logo Synovics Pharmaceuticals, Inc.
Synovics Pharmaceuticals, Inc. (Synovics) is a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of generic over the counter (OTC) pharmaceutical products and generic prescription drug products. The Company is a manufacturer, packager and distributor of private label, or store brand, OTC products to chain drug stores, wholesalers and distributors throughout the United States. The Company’s OTC product categories include analgesics, cough and cold, antihistamines, asthma relief and laxatives. The Company has two primary subsidiaries, Kirk Pharmaceuticals, LLC (Kirk), and ANDAPharm, LLC (ANDAPharm). Kirk manufactures and distributes OTC products developed by or licensed to the Company. ANDAPharm serves as the product research and RX manufacturing arm of the Company with a focus on the development of active compounds for drugs.
Employees
155
  1. Stock Market
  2. Stocks
  3. SYVC Stock